# Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab

> **NCT06167642** · — · ENROLLING_BY_INVITATION · sponsor: **Johns Hopkins University** · enrollment: 75 (estimated)

## Conditions studied

- Multiple Sclerosis
- Tomography, Optical Coherence
- Retinal Degeneration
- Visual Acuity

## Interventions

- **DRUG:** Ofatumumab

## Key facts

- **NCT ID:** NCT06167642
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-05-22
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06167642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06167642, "Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06167642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*